BAMCO Inc’s MiMedx Group MDXG Stock Holding History

BAMCO Inc’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-64,800	Closed	-$770K	–	322
2017 Q3	$770K	Buy	+64,800	New	+$961K	﹤0.01%	302

Other funds holding MDXG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

BAMCO Inc's MDXG Position: Q4 2017 in Review

BAMCO Inc sold out of MiMedx Group (MDXG) in Q4 2017, closing a stake of 64,800 shares — an estimated $770K sold.

BAMCO Inc first reported a position in MDXG in Q3 2017 and held it in 1 quarter. The position peaked at $770K in Q3 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q4 2017.

BAMCO Inc reported no remaining MiMedx Group position as of Q4 2017 after selling out during the quarter.
BAMCO Inc sold 64,800 MiMedx Group shares in Q4 2017, an estimated $770K.
BAMCO Inc first reported a position in MiMedx Group in Q3 2017 and held it in 1 quarter.
BAMCO Inc's MiMedx Group position peaked at $770K in Q3 2017.
237 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2017.

Based on BAMCO Inc's 13F filing for Q4 2017, filed 14 Feb 2018.